S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,023.00 +0.94% CRUDE 81.77 +3.57%
Next Bullish Trade
Sign in
CGC

Canopy Growth Corporation CGC

$0.94 +0.01 (+1.39%)
Pullback · -0.57σ
Mkt cap $0.4B
P/E
Day $0.92 – $0.95
52wk $0.84 – $1.51
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

Canopy Growth Corporation is a Canadian company in the specialty drug manufacturing sector, operating in the cannabis industry. The company produces and distributes cannabis products for both medical and recreational use. As a stock trading on major exchanges, CGC represents ownership in one of the larger players in the legal cannabis market.

The stock closed at $0.94, up 1.39% for the day. Over the past year, shares have traded between $0.84 and $1.51, meaning the current price sits near the lower end of that range. The technical picture shows the stock in a pullback zone, trading about half a standard move below its 21-day average. The RSI reading of 46.0 suggests neutral momentum, neither particularly overbought nor oversold.

Investors following CGC might watch whether the stock stabilizes around current levels or continues to work through this pullback phase. The proximity to the 52-week low of $0.84 could be noteworthy, as that level represents the lowest point reached in the past year. Developments in the cannabis industry, regulatory changes, and the company's quarterly financial results would be typical factors that influence trading activity in this stock.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $1.08 (fair range $1–$2); today's price leaves a +12% cushion below that estimate. The model's verdict is “Undervalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)
$1.08
Fair-value range
$0.76 – $2.02
Margin of safety
+12%
Verdict
Undervalued
Accounting quality Weak
  • ✓ More cash than debt
  • ✓ Quick ratio 2.50 (antifragile)
  • ✓ Current ratio 3.34 (antifragile)
  • ✓ Debt/equity 0.60 (antifragile)
  • ⚠ Negative retained earnings
  • ⚠ Inventory growing faster than revenue

Price implies ~7% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

CGC is a $430 million company, the stock is trading near the bottom of its 52-week range.

Mkt cap $0.4B
P/E ttm
Fwd P/E
Beta
Day range $0.92 – $0.95
52w range $0.84 – $1.51
Avg vol
RSI(2) 46.0
ROE
Net mgn
FCF mgn 5.7%
Debt/Eq 0.40
Div yld
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Next earn
52-week range · today's price
$0.84$1.51

More on CGC